You are here

Douglas Scharre

  • Physician, FGP-Neurology
  • Professor-Clinical, Neurology
  • Associate Professor-Clinical, Psychiatry
  • Room #620
    395 W 12th Ave
    Columbus, OH 43210
  • 614-293-8531

Honors

  • January, 2013

    Best Doctor's in America.

  • June, 2012

    Department of Neurology Graduating Class Resident Mentor Award.

  • January, 2012

    Best Doctor's in America.

  • January, 2011

    Best Doctor's in America.

  • June, 2010

    Ohio State University College of Medicine Excellence in Teaching Award.

  • January, 2010

    Best Doctor's in America.

  • April, 2008-
    April, 2009

    Kippling's Who's Who.

  • April, 2005-
    April, 2009

    National Registry of Who's Who in Executives & Professionals.

  • January, 2009

    Best Doctor's in America.

  • January, 2009

    America's Top Physicians.

  • April, 2007-
    April, 2008

    Global Directory of Who's Who.

  • January, 2008

    Best Doctor's in America.

  • January, 2007

    Best Doctor's in America.

  • January, 2006

    Best Doctor's in America.

  • January, 2006

    Top 100 Health Professionals 2006.

  • April, 2004-
    April, 2005

    Who's Who in Medical Sciences Education.

  • January, 2005

    Best Doctor's in America.

  • April, 2000-
    April, 2001

    National Registry of Who's Who (#145-215).

  • April, 2000-
    April, 2001

    Honored Member of Strathmore's Who's Who.

  • July, 1995

    Monitor's Choice for best site in the E2020-A001-302 Study.

  • April, 1995

    CME Faculty Award of Excellence from The Ohio State University Center for Continuing Medical Education.

  • June, 1991-
    June, 1993

    National Research Award: Funded by the National Institute of Aging (NIA); $70,000.

  • May, 1991

    National Defense Service Medal.

  • May, 1990

    Meritorious Service Medal.

  • May, 1989

    Army Achievement Medal.

  • June, 1983

    Army Service Ribbon.

  • June, 1983

    Armed Forces Reserve Medal.

Chapters

2011

  • 2011. "Dementia, Alzheimer's Disease." In The 5-Minute Neurology Consult, 2nd Edition, edited by In Lynn DJ, Newton HB, Rae-Grant AD,

2010

  • 2010. "Neuropsychiatric Aspects of Neoplastic, Demyelinating, Infectious, and Inflammatory Diseases of the Brain." In American Psychiatric Press Textbook of Geriatric Neuropsychiatry, Third Edition, edited by In Coffey E and Cummings JL,
  • 2010. "Management of Behaviors." In Long-Term Management of Dementia, edited by In Scharre DW,

2007

  • 2007. "Infectious, Inflammatory and Demyelinating Disorders of the Frontal Lobes.." In The Human Frontal Lobes: Functions and Disorders, edited by In Miller BL and Cummings JL,

2006

  • 2006. "Infectious, Inflammatory and Demyelinating Disorders of the Frontal Lobes." In The Human Frontal Lobes: Functions and Disorders, edited by In Miller BL and Cummings JL,

2004

  • 2004. "Dementia, Alzheimer's Disease." In The 5-Minute Neurology Consult, edited by In Lynn DJ, Newton HB, Rae-Grant AD,
  • 2004. "Coma." In The 5-Minute Neurology Consult, edited by In Lynn DJ, Newton HB, Rae-Grant AD,

2000

  • 2000. "Inherited Neurological Disorders: Relevant Considerations and New Aspects." In Clinical Neurology, Revised Edition 2000 Volume 4, edited by In Joynt RJ and Griggs RC,
  • 2000. "Neuropsychiatric Aspects of Neoplastic, Demyelinating, Infectious, and Inflammatory Diseases of the Brain." In American Psychiatric Press Textbook of Geriatric Neuropsychiatry, Second Edition, edited by In Coffey E and Cummings JL,

1999

  • 1999. "Infectious, Inflammatory and Demyelinating Disorders of the Frontal Lobes.." In The Human Frontal Lobes: Functions and Disorders, edited by In Miller BL and Cummings JL,

1998

  • 1998. "Dementia." In Practical Ambulatory Geriatrics, edited by In Yoshikawa TT, Cobbs EL, and Brummel-Smith K,

1997

  • 1997. "Inherited Neurological Disorders: Relevant Considerations and New Aspects." In Clinical Neurology, Revised Edition 1997 Volume 4, edited by In Joynt RJ and Griggs RC,

1993

  • 1993. "Dementia." In Ambulatory Geriatric Care, edited by In Yoshikawa TT, Cobbs EL, and Brummel-Smith K,

Journal Articles

2013

  • Vaughan,Leslie; Espeland,Mark,A; Snively,Beverly; Shumaker,Sally,A; Rapp,Stephen,R; Shupe,Jill; Robinson,Jennifer,G; Sarto,Gloria,E; Resnick,Susan,M, 2013, "The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y)." BRAIN RESEARCH 1514, 3-11 - 3-11.

2012

  • Schott,Jonathan,M, 2012, "Using CSF biomarkers to replicate genetic associations in Alzheimer's disease." NEUROBIOLOGY OF AGING 33, no. 7, 1486.e9 - 1486.e9.
  • Holland,Dominic; McEvoy,Linda,K; Dale,Anders,M, 2012, "Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI." HUMAN BRAIN MAPPING 33, no. 11, 2586-2602 - 2586-2602.
  • Li,Yang; Wang,Yaping; Wu,Guorong; Shi,Feng; Zhou,Luping; Lin,Weili; Shen,Dinggang, 2012, "Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features." NEUROBIOLOGY OF AGING 33, no. 2, 427.e15 - 427.e15.
  • Hurko,Orest; Black,Sandra,E; Doody,Rachelle; Doraiswamy,P,Murali; Gamst,Anthony; Kaye,Jeffrey; Obisesan,Thomas,O; Rusinek,Henry; Scharre,Doug; Sperling,Reisa; Weiner,Michael,W; Green,Robert,C, 2012, "The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors." NEUROIMAGE 59, no. 4, 4196-4200 - 4196-4200.
  • McDonald,Carrie,R; Gharapetian,Lusineh; McEvoy,Linda,K; Fennema-Notestine,Christine; Hagler,Donald,J; Holland,Dominic; Dale,Anders,M, 2012, "Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment." NEUROBIOLOGY OF AGING 33, no. 2, 242-253 - 242-253.
  • Bonner-Jackson,Aaron; Okonkwo,Ozioma; Tremont,Geoffrey, 2012, "Apolipoprotein E epsilon 2 and Functional Decline in Amnestic Mild Cognitive Impairment and Alzheimer Disease." AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY 20, no. 7, 584-593 - 584-593.
  • Schuff,Norbert; Tosun,Duygu; Insel,Philip,S; Chiang,Gloria,C; Truran,Diana; Aisen,Paul,S; Jack,Clifford,R; Weiner,Michael,W, 2012, "Nonlinear time course of brain volume loss in cognitively normal and impaired elders." NEUROBIOLOGY OF AGING 33, no. 5, 845-855 - 845-855.
  • Samtani,Mahesh,N; Farnum,Michael; Lobanov,Victor; Yang,Eric; Raghavan,Nandini; Dibernardo,Allitia; Narayan,Vaibhav, 2012, "An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative." JOURNAL OF CLINICAL PHARMACOLOGY 52, no. 5, 629-644 - 629-644.

2011

  • Dickerson,Bradford,C; Wolk,David,A, 2011, "Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics." JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 82, no. 1, 45-51 - 45-51.
  • Bakken,Trygve,E; Dale,Anders,M; Schork,Nicholas,J, 2011, "A Geographic Cline of Skull and Brain Morphology among Individuals of European Ancestry." HUMAN HEREDITY 72, no. 1, 35-44 - 35-44.
  • Lo,Raymond,Y; Hubbard,Alan,E; Shaw,Leslie,M; Trojanowski,John,Q; Jack,Clifford,R; Petersen,Ronald,C; Aisen,Paul,S; Weiner,Michael,W; Jagust,William,J, 2011, "Longitudinal Change of Biomarkers in Cognitive Decline." NEUROLOGY 76, no. 9, A5-A5 - A5-A5.
  • Yang,Wenlu; Lui,Ronald,LM; Gao,Jia-Hong; Chan,Tony,F; Yau,Shing-Tung; Sperling,Reisa,A; Huang,Xudong, 2011, "Independent Component Analysis-Based Classification of Alzheimer's Disease MRI Data (vol 24, pg 775, 2011)." JOURNAL OF ALZHEIMERS DISEASE 27, no. 1, 239-239 - 239-239.
  • Scharre DW, 2011, "Normal pressure hydrocephalus: Measure twice, shunt once." Neurology 77, 1110-1111 - 1110-1111.
  • Lopez,M; RAMIREZ,J; Gorriz,J,M; Alvarez,I; Salas-Gonzalez,D; Segovia,F; Chaves,R; Padilla,P; Gomez-Rio,M, 2011, "Principal component analysis-based techniques and supervised classification schemes for the early detection of Alzheimer's disease." NEUROCOMPUTING 74, no. 8, 1260-1271 - 1260-1271.
  • Antunez,Carmen; Boada,Merce; Gonzalez-Perez,Antonio; Gayan,Javier; Ramirez-Lorca,Reposo; Marin,Juan; Hernandez,Isabel; Moreno-Rey,Concha; Jesus Moron,Francisco; Lopez-Arrieta,Jesus; Mauleon,Ana; Rosende-Roca,Maitee; Noguera-Perea,Fuensanta; Legaz-Garcia,Agustina; Vivancos-Moreau,Laura; Velasco,Juan; Miguel Carrasco,Jose; Alegret,Montserrat; Antequera-Torres,Martirio; Manzanares,Salvadora; Romo,Alejandro; Blanca,Irene; Ruiz,Susana; Espinosa,Anna; Castano,Sandra; Garcia,Blanca; Martinez-Herrada,Begona; Vinyes,Georgina; Lafuente,Asuncion; Becker,James,T; Jorge Galan,Jose; Serrano-Rios,Manuel; Vazquez,Enrique; Tarraga,Lluis; Eugenia Saez,Maria; Lopez,Oscar,L; Miguel Real,Luis; Ruiz,Agustin, 2011, "The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease." GENOME MEDICINE 3, 33 - 33.
  • Landau,Susan,M; Harvey,Danielle; Madison,Cindee,M; Koeppe,Robert,A; Reiman,Eric,M; Foster,Norman,L; Weiner,Michael,W; Jagust,William,J, 2011, "Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI." NEUROBIOLOGY OF AGING 32, no. 7, 1207-1218 - 1207-1218.
  • Schneider,Lon,S; Insel,Philip,S; Weiner,Michael,W, 2011, "Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative." ARCHIVES OF NEUROLOGY 68, no. 1, 58-66 - 58-66.
  • Dukart,Juergen; Mueller,Karsten; Horstmann,Annette; Barthel,Henryk; Moeller,Harald,E; Villringer,Arno; Sabri,Osama; Schroeter,Matthias,L, 2011, "Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia." PLOS ONE 6, no. 3, e18111 - e18111.
  • Mattila,Jussi; Koikkalainen,Juha; Virkki,Arho; Simonsen,Anja; Van Gils,Mark; Waldemar,Gunhild; Soininen,Hilkka; Lotjonen,Jyrki, 2011, "A Disease State Fingerprint for Evaluation of Alzheimer's Disease." JOURNAL OF ALZHEIMERS DISEASE 27, no. 1, 163-176 - 163-176.
  • Herholz,Karl; Westwood,Sarah; Haense,Cathleen; Dunn,Graham, 2011, "Evaluation of a Calibrated F-18-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment." JOURNAL OF NUCLEAR MEDICINE 52, no. 8, 1218-1226 - 1218-1226.
  • Cuingnet,Remi; Gerardin,Emilie; Tessieras,Jerome; Auzias,Guillaume; Lehericy,Stephane; Habert,Marie-Odile; Chupin,Marie; Benali,Habib; Colliot,Olivier, 2011, "Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of ten methods using the ADNI database." NEUROIMAGE 56, no. 2, 766-781 - 766-781.
  • Marshall,Gad,A; Rentz,Dorene,M; Frey,Meghan,T; Locascio,Joseph,J; Johnson,Keith,A; Sperling,Reisa,A, 2011, "Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease." ALZHEIMERS & DEMENTIA 7, no. 3, 300-308 - 300-308.
  • Thompson,Wesley,K; Holland,Dominic, 2011, "Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates." NEUROIMAGE 57, no. 1, 1-4 - 1-4.
  • Heckemann,Rolf,A; Keihaninejad,Shiva; Aljabar,Paul; Gray,Katherine,R; Nielsen,Casper; Rueckert,Daniel; Hajnal,Joseph,V; Hammers,Alexander, 2011, "Automatic morphometry in Alzheimer's disease and mild cognitive impairment." NEUROIMAGE 56, no. 4, 2024-2037 - 2024-2037.
  • Bossa,Matias; Zacur,Ernesto; Olmos,Salvador, 2011, "Statistical analysis of relative pose information of subcortical nuclei: Application on ADNI data." NEUROIMAGE 55, no. 3, 999-1008 - 999-1008.
  • Abdulkadir,Ahmed; Mortamet,Benedicte; Vemuri,Prashanthi; Jack,Clifford,R; Krueger,Gunnar; Kloeppel,Stefan, 2011, "Effects of hardware heterogeneity on the performance of SVM Alzheimer's disease classifier." NEUROIMAGE 58, no. 3, 785-792 - 785-792.
  • Tractenberg,Rochelle,E; Pietrzak,Robert,H, 2011, "Intra-Individual Variability in Alzheimer's Disease and Cognitive Aging: Definitions, Context, and Effect Sizes." PLOS ONE 6, no. 4, e16973 - e16973.
  • Skup,Martha; Zhu,Hongtu; Wang,Yaping; Giovanello,Kelly,S; Lin,Ja-an; Shen,Dinggang; Shi,Feng; Gao,Wei; Lin,Weili; Fan,Yong; Zhang,Heping, 2011, "Sex differences in grey matter atrophy patterns among AD and aMCI patients: Results from ADNI." NEUROIMAGE 56, no. 3, 890-906 - 890-906.
  • Kim,S; Swaminathan,S; Shen,L; Risacher,S,L; Nho,K; Foroud,T; Shaw,L,M; Trojanowski,J,Q; Potkin,S,G; Huentelman,M,J; Craig,D,W; Dechairo,B,M; Aisen,P,S; PETERSEN,R,C; Weiner,M,W; Saykin,A,J, 2011, "Genome-wide association study of CSF biomarkers A beta(1-42), t-tau, and p-tau(181p) in the ADNI cohort." NEUROLOGY 76, no. 1, 69-79 - 69-79.
  • Silver,Matt; Montana,Giovanni; Nichols,Thomas,E, 2011, "False positives in neuroimaging genetics using voxel-based morphometry data." NEUROIMAGE 54, no. 2, 992-1000 - 992-1000.
  • Holland,Dominic; Dale,Anders,M, 2011, "Nonlinear registration of longitudinal images and measurement of change in regions of interest." MEDICAL IMAGE ANALYSIS 15, no. 4, 489-497 - 489-497.
  • Thompson,Wesley,K; Hallmayer,Joachim; O'Hara,Ruth, 2011, "Design Considerations for Characterizing Psychiatric Trajectories Across the Lifespan: Application to Effects of APOE-epsilon 4 on Cerebral Cortical Thickness in Alzheimer's Disease." AMERICAN JOURNAL OF PSYCHIATRY 168, no. 9, 894-903 - 894-903.
  • Swaminathan,Shanker; Kim,Sungeun; Shen,Li; Risacher,Shannon,L; Foroud,Tatiana; Pankratz,Nathan; Potkin,Steven,G; Huentelman,Matthew,J; Craig,David,W; Weiner,Michael,W; Saykin,Andrew,J; The Alzheimer's Disease Neuroimaging Initiative Adni, 2011, "Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study.." International journal of Alzheimer's disease 2011, 729478-? - 729478-?.
  • Llano,Daniel,A; Laforet,Genevieve; Devanarayan,Viswanath, 2011, "Derivation of a New ADAS-cog Composite Using Tree-based Multivariate Analysis Prediction of Conversion From Mild Cognitive Impairment to Alzheimer Disease." ALZHEIMER DISEASE & ASSOCIATED DISORDERS 25, no. 1, 73-84 - 73-84.
  • Stricker,N,H; Chang,Y-L; Fennema-Notestine,C; Delano-Wood,L; Salmon,D,P; Bondi,M,W; Dale,A,M, 2011, "Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease." NEUROLOGY 77, no. 8, 713-721 - 713-721.
  • Markiewicz,P,J; Matthews,J,C; Declerck,J; Herholz,K, 2011, "Verification of predicted robustness and accuracy of multivariate analysis." NEUROIMAGE 56, no. 3, 1382-1385 - 1382-1385.
  • Pelaez-Coca,Mariola; Bossa,Matias; Olmos,Salvador, 2011, "Discrimination of AD and normal subjects from MRI: Anatomical versus statistical regions." NEUROSCIENCE LETTERS 487, no. 1, 113-117 - 113-117.
  • Zhang,Daoqiang; Wang,Yaping; Zhou,Luping; Yuan,Hong; Shen,Dinggang, 2011, "Multimodal classification of Alzheimer's disease and mild cognitive impairment." NEUROIMAGE 55, no. 3, 856-867 - 856-867.
  • Park,Hyunjin; Seo,Jongbum, 2011, "Application of multidimensional scaling to quantify shape in Alzheimer's disease and its correlation with Mini Mental State Examination: A feasibility study." JOURNAL OF NEUROSCIENCE METHODS 194, no. 2, 380-385 - 380-385.
  • Filipovych,Roman; Davatzikos,Christos, 2011, "Semi-supervised pattern classification of medical images: Application to mild cognitive impairment (MCI)." NEUROIMAGE 55, no. 3, 1109-1119 - 1109-1119.
  • Illan,I,A; Gorriz,J,M; RAMIREZ,J; Salas-Gonzalez,D; Lopez,M,M; Segovia,F; Chaves,R; Gomez-Rio,M; Puntonet,C,G, 2011, "F-18-FDG PET imaging analysis for computer aided Alzheimer's diagnosis." INFORMATION SCIENCES 181, no. 4, 903-916 - 903-916.
  • Jun,G, 2011, "Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes (vol 67, pg 1473, 2010)." ARCHIVES OF NEUROLOGY 68, no. 2, 159-159 - 159-159.
  • Rajagopalan,Priya; Hua,Xue; Toga,Arthur,W; Jack,Clifford,R; Weiner,Michael,W; Thompson,Paul,M, 2011, "Homocysteine effects on brain volumes mapped in 732 elderly individuals." NEUROREPORT 22, no. 8, 391-395 - 391-395.
  • Cardoso,M,Jorge; Clarkson,Matthew,J; Ridgway,Gerard,R; Modat,Marc; Fox,Nick,C; Ourselin,Sebastien, 2011, "LoAd: A locally adaptive cortical segmentation algorithm." NEUROIMAGE 56, no. 3, 1386-1397 - 1386-1397.
  • Chiang,Gloria,C; Insel,Philip,S; Tosun,Duygu; Schuff,Norbert; Truran-Sacrey,Diana; Raptentsetsang,Sky; Jack,Clifford,R; Weiner,Michael,W, 2011, "Identifying Cognitively Healthy Elderly Individuals with Subsequent Memory Decline by Using Automated MR Temporoparietal Volumes." RADIOLOGY 259, no. 3, 844-851 - 844-851.
  • Donohue,M,C; Gamst,A,C; Thomas,R,G; Xu,R; Beckett,L; PETERSEN,R,C; Weiner,M,W; Aisen,P, 2011, "The relative efficiency of time-to-threshold and rate of change in longitudinal data." CONTEMPORARY CLINICAL TRIALS 32, no. 5, 685-693 - 685-693.
  • Wolk,David,A; Dickerson,Bradford,C, 2011, "Fractionating verbal episodic memory in Alzheimer's disease." NEUROIMAGE 54, no. 2, 1530-1539 - 1530-1539.
  • Spampinato,Maria,Vittoria; Rumboldt,Zoran; Hosker,Robert,J; Mintzer,Jacobo,E, 2011, "Apolipoprotein E and Gray Matter Volume Loss in Patients with Mild Cognitive Impairment and Alzheimer Disease." RADIOLOGY 258, no. 3, 843-852 - 843-852.
  • Antúnez,Carmen; Boada,Mercè; López-Arrieta,Jesús; Moreno-Rey,Concha; Hernández,Isabel; Marín,Juan; Gayán,Javier; González-Pérez,Antonio; Real,Luis,M; Alegret,Montserrat; Tárraga,Lluis; Ramírez-Lorca,Reposo; Ruiz,Agustín, 2011, "Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease.." Alzheimer's & dementia : the journal of the Alzheimer's Association 7, no. 4, e124-9 - e124-9.
  • Cuingnet,Remi; Rosso,Charlotte; Chupin,Marie; Lehericy,Stephane; Dormont,Didier; Benali,Habib; Samson,Yves; Colliot,Olivier, 2011, "Spatial regularization of SVM for the detection of diffusion alterations associated with stroke outcome." MEDICAL IMAGE ANALYSIS 15, no. 5, 729-737 - 729-737.
  • Chen,Kewei; Ayutyanont,Napatkamon; Langbaum,Jessica,BS; Fleisher,Adam,S; Reschke,Cole; Lee,Wendy; Liu,Xiaofen; Bandy,Dan; Alexander,Gene,E; Thompson,Paul,M; Shaw,Leslie; Trojanowski,John,Q; Jack,Clifford,R; Landau,Susan,M; Foster,Norman,L; Harvey,Danielle,J; Weiner,Michael,W; Koeppe,Robert,A; Jagust,William,J; Reiman,Eric,M, 2011, "Characterizing Alzheimer's disease using a hypometabolic convergence index." NEUROIMAGE 56, no. 1, 52-60 - 52-60.
  • Zhang,Tianhao; Davatzikos,Christos, 2011, "ODVBA: Optimally-Discriminative Voxel-Based Analysis." IEEE TRANSACTIONS ON MEDICAL IMAGING 30, no. 8, 1441-1454 - 1441-1454.
  • Erten-Lyons,Deniz; Wilmot,Beth; Anur,Pavana; McWeeney,Shannon; Westaway,Shawn,K; Silbert,Lisa; Kramer,Patricia; Kaye,Jeffrey, 2011, "Microcephaly Genes and Risk of Late-onset Alzheimer Disease." ALZHEIMER DISEASE & ASSOCIATED DISORDERS 25, no. 3, 276-282 - 276-282.
  • Cover,Keith,S; van Schijndel,Ronald,A; van Dijk,Bob,W; Redolfi,Alberto; Knol,Dirk,L; Frisoni,Giovanni,B; Barkhof,Frederik; Vrenken,Hugo, 2011, "Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans." PSYCHIATRY RESEARCH-NEUROIMAGING 193, no. 3, 182-190 - 182-190.
  • Stein,J,L; Hibar,D,P; Madsen,S,K; Khamis,M; McMahon,K,L; de Zubicaray,G,I; Hansell,N,K; Montgomery,G,W; Martin,N,G; Wright,M,J; Saykin,A,J; Jack,C,R; Weiner,M,W; Toga,A,W; Thompson,P,M, 2011, "Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search." MOLECULAR PSYCHIATRY 16, no. 9, 927-937 - 927-937.
  • Davatzikos,Christos; Bhatt,Priyanka; Shaw,Leslie,M; Batmanghelich,Kayhan,N; Trojanowski,John,Q, 2011, "Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification." NEUROBIOLOGY OF AGING 32, no. 12, 2322.e19 - 2322.e19.
  • Koikkalainen,Juha; Lotjonen,Jyrki; Thurfjell,Lennart; Rueckert,Daniel; Waldemar,Gunhild; Soininen,Hilkka, 2011, "Multi-template tensor-based morphometry: Application to analysis of Alzheimer's disease." NEUROIMAGE 56, no. 3, 1134-1144 - 1134-1144.
  • Dukart,Juergen; Schroeter,Matthias,L; Mueller,Karsten, 2011, "Age Correction in Dementia - Matching to a Healthy Brain." PLOS ONE 6, no. 7, e22193 - e22193.
  • Hua,Xue; Gutman,Boris; Boyle,Christina,P; Rajagopalan,Priya; Leow,Alex,D; Yanovsky,Igor; Kumar,Anand,R; Toga,Arthur,W; Jack,Clifford,R; Schuff,Norbert; Alexander,Gene,E; Chen,Kewei; Reiman,Eric,M; Weiner,Michael,W; Thompson,Paul,M, 2011, "Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry." NEUROIMAGE 57, no. 1, 5-14 - 5-14.
  • Lotjonen,Jyrki; Wolz,Robin; Koikkalainen,Juha; Julkunen,Valtteri; Thurfjell,Lennart; Lundqvist,Roger; Waldemar,Gunhild; Soininen,Hilkka; Rueckert,Daniel, 2011, "Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease." NEUROIMAGE 56, no. 1, 185-196 - 185-196.
  • Shaw,Leslie,M; Vanderstichele,Hugo; Knapik-Czajka,Malgorzata; Figurski,Michal; Coart,Els; Blennow,Kaj; Soares,Holly; Simon,Adam,J; Lewczuk,Piotr; Dean,Robert,A; Siemers,Eric; Potter,William; Lee,Virginia,MY; Trojanowski,John,Q, 2011, "Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI." ACTA NEUROPATHOLOGICA 121, no. 5, 597-609 - 597-609.
  • Hibar,Derrek,P; Stein,Jason,L; Kohannim,Omid; Jahanshad,Neda; Saykin,Andrew,J; Shen,Li; Kim,Sungeun; Pankratz,Nathan; Foroud,Tatiana; Huentelman,Matthew,J; Potkin,Steven,G; Jack,Clifford,R; Weiner,Michael,W; Toga,Arthur,W; Thompson,Paul,M, 2011, "Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects." NEUROIMAGE 56, no. 4, 1875-1891 - 1875-1891.

2010

  • Jack,Clifford,R; Wiste,Heather,J; Vemuri,Prashanthi; Weigand,Stephen,D; Senjem,Matthew,L; Zeng,Guang; Bernstein,Matt,A; Gunter,Jeffrey,L; Pankratz,Vernon,S; Aisen,Paul,S; Weiner,Michael,W; Petersen,Ronald,C; Shaw,Leslie,M; Trojanowski,John,Q; Knopman,David,S, 2010, "Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease." BRAIN 133, 3336-3348 - 3336-3348.
  • Shen,Li; Kim,Sungeun; Risacher,Shannon,L; Nho,Kwangsik; Swaminathan,Shanker; West,John,D; Foroud,Tatiana; Pankratz,Nathan; Moore,Jason,H; Sloan,Chantel,D; Huentelman,Matthew,J; Craig,David,W; Dechairo,Bryan,M; Potkin,Steven,G; Jack,Clifford,R; Weiner,Michael,W; Saykin,Andrew,J, 2010, "Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort." NEUROIMAGE 53, no. 3, 1051-1063 - 1051-1063.
  • Li,Yang; Wang,Yaping; Xue,Zhong; Shi,Feng; Lin,Weili; Shen,Dinggang, 2010, "Consistent 4D cortical thickness measurement for longitudinal neuroimaging study.." Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 13, 133-142 - 133-142.
  • Murphy,E,A; Holland,D; Donohue,M; McEvoy,L,K; Hagler,D,J; Dale,A,M; Brewer,J,B, 2010, "Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls." NEUROIMAGE 53, no. 4, 1310-1317 - 1310-1317.
  • Schneider,Lon,S; Kennedy,Richard,E; Cutter,Gary,R, 2010, "Requiring an amyloid-beta(1-42) biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials." ALZHEIMERS & DEMENTIA 6, no. 5, 367-377 - 367-377.
  • Lakatos,Anita; Derbeneva,Olga; Younes,Danny; Keator,David; Bakken,Trygve; Lvova,Maria; Brandon,Marty; Guffanti,Guia; Reglodi,Dora; Saykin,Andrew; Weiner,Michael; Macciardi,Fabio; Schork,Nicholas; Wallace,Douglas,C; Potkin,Steven,G, 2010, "Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort." NEUROBIOLOGY OF AGING 31, no. 8, 1355-1363 - 1355-1363.
  • Lemoine,Blake; Rayburn,Sara; Benton,Ryan, 2010, "Data Fusion and Feature Selection for Alzheimer's Diagnosis." BRAIN INFORMATICS, BI 2010 6334, 320-327 - 320-327.
  • Kohannim,Omid; Hua,Xue; Hibar,Derrek,P; Lee,Suh; Chou,Yi-Yu; Toga,Arthur,W; Jack,Clifford,R; Weiner,Michael,W; Thompson,Paul,M, 2010, "Boosting power for clinical trials using classifiers based on multiple biomarkers." NEUROBIOLOGY OF AGING 31, no. 8, 1429-1442 - 1429-1442.
  • Nettiksimmons,J; Harvey,D; Brewer,J; Carmichael,O; Decarli,C; Jack,C,R; Petersen,R; Shaw,L,M; Trojanowski,J,Q; Weiner,M,W; Beckett,L, 2010, "Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline." NEUROBIOLOGY OF AGING 31, no. 8, 1419-1428 - 1419-1428.
  • Shen,Li; Qi,Yuan; Kim,Sungeun; Nho,Kwangsik; Wan,Jing; Risacher,Shannon,L; Saykin,Andrew,J, 2010, "Sparse Bayesian Learning for Identifying Imaging Biomarkers in AD Prediction." MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2010, PT III 6363, 611-618 - 611-618.
  • Habeck,Christian; Stern,Yaakov, 2010, "Multivariate Data Analysis for Neuroimaging Data: Overview and Application to Alzheimer's Disease." CELL BIOCHEMISTRY AND BIOPHYSICS 58, no. 2, 53-67 - 53-67.
  • Vemuri,Prashanthi; Wiste,Heather,J; Weigand,Stephen,D; Knopman,David,S; Shaw,Leslie,M; Trojanowski,John,Q; Aisen,Paul,S; Weiner,Michael; Petersen,Ronald,C; Jack,Clifford,R, 2010, "Effect of Apolipoprotein E on Biomarkers of Amyloid Load and Neuronal Pathology in Alzheimer Disease." ANNALS OF NEUROLOGY 67, no. 3, 308-316 - 308-316.
  • Ito,Kaori; Ahadieh,Sima; Corrigan,Brian; French,Jonathan; Fullerton,Terence; Tensfeldt,Thomas, 2010, "Disease progression meta-analysis model in Alzheimer's disease." ALZHEIMERS & DEMENTIA 6, no. 1, 39-53 - 39-53.
  • Trojanowski,John,Q; Vandeerstichele,Hugo; Korecka,Magdalena; Clark,Christopher,M; Aisen,Paul,S; Petersen,Ronald,C; Blennow,Kaj; Soares,Holly; Simon,Adam; Lewczuk,Piotr; Dean,Robert; Siemers,Eric; Potter,William,Z; Weiner,Michael,W; Jack,Clifford,R; Jagust,William; Toga,Arthur,W; Lee,Virginia,MY; Shaw,Leslie,M, 2010, "Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects." ALZHEIMERS & DEMENTIA 6, no. 3, 230-238 - 230-238.
  • Saykin,Andrew,J; Shen,Li; Foroud,Tatiana,M; Potkin,Steven,G; Swaminathan,Shanker; Kim,Sungeun; Risacher,Shannon,L; Nho,Kwangsik; Huentelman,Matthew,J; Craig,David,W; Thompson,Paul,M; Stein,Jason,L; Moore,Jason,H; Farrer,Lindsay,A; Green,Robert,C; Bertram,Lars; Jack,Clifford,R; Weiner,Michael,W, 2010, "Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans." ALZHEIMERS & DEMENTIA 6, no. 3, 265-273 - 265-273.
  • Chang,Yu-Ling; Jacobson,Mark,W; Fennema-Notestine,Christine; Hagler,Donald,J; Jennings,Robin,G; Dale,Anders,M; McEvoy,Linda,K, 2010, "Level of Executive Function Influences Verbal Memory in Amnestic Mild Cognitive Impairment and Predicts Prefrontal and Posterior Cingulate Thickness." CEREBRAL CORTEX 20, no. 6, 1305-1313 - 1305-1313.
  • Kauwe,J,SK; Bertelsen,S; Mayo,K; Cruchaga,C; Abraham,R; Hollingworth,P; Harold,D; Owen,M,J; Williams,J; Lovestone,S; Morris,J,C; Goate,A,M, 2010, "Suggestive Synergy Between Genetic Variants in TF and HFE as Risk Factors for Alzheimer's Disease." AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 153B, no. 4, 955-959 - 955-959.
  • Madsen,S,K; Ho,A,J; Hua,X; Saharan,P,S; Toga,A,W; Jack,C,R; Weiner,M,W; Thompson,P,M, 2010, "3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects." NEUROBIOLOGY OF AGING 31, no. 8, 1312-1325 - 1312-1325.
  • Habeck,Christian,Georg, 2010, "Basics of multivariate analysis in neuroimaging data.." Journal of visualized experiments : JoVE -, no. 41, 1988 - 1988.
  • Lotjonen,Jyrki,MP; Wolz,Robin; Koikkalainen,Juha,R; Thurfjell,Lennart; Waldemar,Gunhild; Soininen,Hilkka; Rueckert,Daniel, 2010, "Fast and robust multi-atlas segmentation of brain magnetic resonance images." NEUROIMAGE 49, no. 3, 2352-2365 - 2352-2365.
  • Chen,Wei; Song,Xiaowei; Zhang,Yunting; Darvesh,Sultan; Zhang,Ningnannan; D'Arcy,Ryan,CN; Black,Sandra; Rockwood,Kenneth, 2010, "An MRI-Based Semiquantitative Index for the Evaluation of Brain Atrophy and Lesions in Alzheimer's Disease, Mild Cognitive Impairment and Normal Aging." DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 30, no. 2, 121-130 - 121-130.
  • Epstein,Noam,U; Saykin,Andrew,J; Risacher,Shannon,L; Gao,Sujuan; Farlow,Martin,R, 2010, "Differences in Medication Use in the Alzheimer's Disease Neuroimaging Initiative Analysis of Baseline Characteristics." DRUGS & AGING 27, no. 8, 677-686 - 677-686.
  • Chiang,G,C; Insel,P,S; Tosun,D; Schuff,N; Truran-Sacrey,D; Raptentsetsang,S,T; Jack,C,R; Aisen,P,S; PETERSEN,R,C; Weiner,M,W, 2010, "Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects." NEUROLOGY 75, no. 22, 1976-1981 - 1976-1981.
  • Cuingnet,Remi; Chupin,Marie; Benali,Habib; Colliot,Olivier, 2010, "Spatial prior in SVM-based classification of brain images." MEDICAL IMAGING 2010: COMPUTER - AIDED DIAGNOSIS 7624, 76241L - 76241L.
  • Salas-Gonzalez,D; Gorriz,J,M; RAMIREZ,J; Illan,I,A; Lopez,M; Segovia,F; Chaves,R; Padilla,P; Puntonet,C,G, 2010, "Feature selection using factor analysis for Alzheimer's diagnosis using F-18-FDG PET images." MEDICAL PHYSICS 37, no. 11, 6084-6095 - 6084-6095.
  • Greene,Sarah,J; Killiany,Ronald,J, 2010, "Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease." NEUROBIOLOGY OF AGING 31, no. 8, 1304-1311 - 1304-1311.
  • Hua,Xue; Hibar,Derrek,P; Lee,Suh; Toga,Arthur,W; Jack,Clifford,R; Weiner,Michael,W; Thompson,Paul,M, 2010, "Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans." NEUROBIOLOGY OF AGING 31, no. 8, 1463-1480 - 1463-1480.
  • Wu,Xia; Chen,Kewei; Yao,Li; Ayutyanont,Napatkamon; Langbaum,Jessica,BS; Fleisher,Adam; Reschke,Cole; Lee,Wendy; Liu,Xiaofen; Alexander,Gene,E; Bandy,Dan; Foster,Norman,L; Thompson,Paul,M; Harvey,Danielle,J; Weiner,Michael,W; Koeppe,Robert,A; Jagust,William,J; Reiman,Eric,M, 2010, "Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment." JOURNAL OF NEUROSCIENCE METHODS 192, no. 2, 277-285 - 277-285.
  • Weiner,Michael,W; Aisen,Paul,S; Jack,Clifford,R; Jagust,William,J; Trojanowski,John,Q; Shaw,Leslie; Saykin,Andrew,J; Morris,John,C; Cairns,Nigel; Beckett,Laurel,A; Toga,Arthur; Green,Robert; Walter,Sarah; Soares,Holly; Snyder,Peter; Siemers,Eric; Potter,William; Cole,Patricia,E; Schmidt,Mark, 2010, "The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans." ALZHEIMERS & DEMENTIA 6, no. 3, 202-211 - 202-211.
  • Carmichael,Owen; Schwarz,Christopher; Drucker,David; Fletcher,Evan; Harvey,Danielle; Beckett,Laurel; Jack,Clifford,R; Weiner,Michael; DeCarli,Charles, 2010, "Longitudinal Changes in White Matter Disease and Cognition in the First Year of the Alzheimer Disease Neuroimaging Initiative." ARCHIVES OF NEUROLOGY 67, no. 11, 1370-1378 - 1370-1378.
  • Scharre DW; Chang SI; Murden RA; Lamb J; Beversdorf DQ; Kataki M; Nagaraja HN; Bornstein RA, 2010, "Self-administered Gerocognitive Examination (SAGE) A Brief Cognitive Assessment Instrument for Mild Cognitive Impairment (MCI) and Early Dementia." ALZHEIMER DISEASE & ASSOCIATED DISORDERS 24, no. 1, 64-71 - 64-71.
  • Cairns,Nigel,J; Taylor-Reinwald,Lisa; Morris,John,C, 2010, "Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: The essential role of the Neuropathology Core." ALZHEIMERS & DEMENTIA 6, no. 3, 274-279 - 274-279.
  • Biffi,Alessandro; Anderson,Christopher,D; Desikan,Rahul,S; Sabuncu,Mert; Cortellini,Lynelle; Schmansky,Nick; Salat,David; Rosand,Jonathan, 2010, "Genetic Variation and Neuroimaging Measures in Alzheimer Disease." ARCHIVES OF NEUROLOGY 67, no. 6, 677-685 - 677-685.
  • Ho,April,J; Raji,Cyrus,A; Becker,James,T; Lopez,Oscar,L; Kuller,Lewis,H; Hua,Xue; Lee,Suh; Hibar,Derrek; Dinov,Ivo,D; Stein,Jason,L; Jack,Clifford,R; Weiner,Michael,W; Toga,Arthur,W; Thompson,Paul,M, 2010, "Obesity is linked with lower brain volume in 700 AD and MCI patients." NEUROBIOLOGY OF AGING 31, no. 8, 1326-1339 - 1326-1339.
  • Walhovd,K,B; Fjell,A,M; Dale,A,M; McEvoy,L,K; Brewer,J; Karow,D,S; Salmon,D,P; Fennema-Notestine,C, 2010, "Multi-modal imaging predicts memory performance in normal aging and cognitive decline." NEUROBIOLOGY OF AGING 31, no. 7, 1107-1121 - 1107-1121.
  • Chen,Kewei; Langbaum,Jessica,BS; Fleisher,Adam,S; Ayutyanont,Napatkamon; Reschke,Cole; Lee,Wendy; Liu,Xiaofen; Bandy,Dan; Alexander,Gene,E; Thompson,Paul,M; Foster,Norman,L; Harvey,Danielle,J; de Leon,Mony,J; Koeppe,Robert,A; Jagust,William,J; Weiner,Michael,W; Reiman,Eric,M, 2010, "Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative." NEUROIMAGE 51, no. 2, 654-664 - 654-664.
  • De Meyer,Geert; Shapiro,Fred; Vanderstichele,Hugo; Vanmechelen,Eugeen; Engelborghs,Sebastiaan; De Deyn,Peter,Paul; Coart,Els; Hansson,Oskar; Minthon,Lennart; Zetterberg,Henrik; Blennow,Kaj; Shaw,Leslie; Trojanowski,John,Q, 2010, "Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People." ARCHIVES OF NEUROLOGY 67, no. 8, 949-956 - 949-956.
  • Huang,Shuai; Li,Jing; Sun,Liang; Ye,Jieping; Fleisher,Adam; Wu,Teresa; Chen,Kewei; Reiman,Eric, 2010, "Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation." NEUROIMAGE 50, no. 3, 935-949 - 935-949.
  • Zhang,Tianhao; Davatzikos,Christos, 2010, "Optimally-Discriminative Voxel-Based Analysis." MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2010, PT II, 6362, 257-265 - 257-265.
  • Fjell,Anders,M; Westlye,Lars,T; Espeseth,Thomas; Reinvang,Ivar; Dale,Anders,M; Holland,Dominic; Walhovd,Kristine,B, 2010, "Cortical Gray Matter Atrophy in Healthy Aging Cannot Be Explained by Undetected Incipient Cognitive Disorders: A Comment on Burgmans et al. (2009)." NEUROPSYCHOLOGY 24, no. 2, 258-263 - 258-263.
  • Tosun,Duygu; Schuff,Norbert; Truran-Sacrey,Diana; Shaw,Leslie,M; Trojanowski,John,Q; Aisen,Paul; Peterson,Ronald; Weiner,Michael,W, 2010, "Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study." NEUROBIOLOGY OF AGING 31, no. 8, 1340-1354 - 1340-1354.
  • Fjell,Anders,M; Walhovd,Kristine,B; Fennema-Notestine,Christine; McEvoy,Linda,K; Hagler,Donald,J; Holland,Dominic; Blennow,Kaj; Brewer,James,B; Dale,Anders,M, 2010, "Brain Atrophy in Healthy Aging Is Related to CSF Levels of A beta 1-42." CEREBRAL CORTEX 20, no. 9, 2069-2079 - 2069-2079.
  • Bauer,Corinna,M; Jara,Hernan; Killiany,Ron, 2010, "Whole brain quantitative T2 MRI across multiple scanners with dual echo FSE: Applications to AD, MCI, and normal aging." NEUROIMAGE 52, no. 2, 508-514 - 508-514.
  • Okonkwo,Ozioma,C; Alosco,Michael,L; Jerskey,Beth,A; Sweet,Lawrence,H; Ott,Brian,R; Tremont,Geoffrey, 2010, "Cerebral atrophy, apolipoprotein E epsilon 4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment." ALZHEIMERS & DEMENTIA 6, no. 5, 404-411 - 404-411.
  • Chang,Yu-Ling; Bondi,Mark,W; Fennema-Notestine,Christine; McEvoy,Linda,K; Hagler,Donald,J; Jacobson,Mark,W; Dale,Anders,M, 2010, "Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease." NEUROPSYCHOLOGIA 48, no. 5, 1237-1247 - 1237-1247.
  • Caroli,A; Frisoni,G,B, 2010, "The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort." NEUROBIOLOGY OF AGING 31, no. 8, 1263-1274 - 1263-1274.
  • Beckett,Laurel,A; Harvey,Danielle,J; Gamst,Anthony; Donohue,Michael; Kornak,John; Zhang,Hao; Kuo,Julie,H, 2010, "The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes." ALZHEIMERS & DEMENTIA 6, no. 3, 257-264 - 257-264.
  • Karow,David,S; McEvoy,Linda,K; Fennema-Notestine,Christine; Hagler,Donald,J; Jennings,Robin,G; Brewer,James,B; Hoh,Carl,K; Dale,Anders,M, 2010, "Relative Capability of MR Imaging and FDG PET to Depict Changes Associated with Prodromal and Early Alzheimer Disease." RADIOLOGY 256, no. 3, 932-942 - 932-942.
  • Wolk,David,A; Dickerson,Bradford,C, 2010, "Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 107, no. 22, 10256-10261 - 10256-10261.
  • Heckemann,Rolf,A; Keihaninejad,Shiva; Aljabar,Paul; Rueckert,Daniel; Hajnal,Joseph,V; Hammers,Alexander, 2010, "Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation." NEUROIMAGE 51, no. 1, 221-227 - 221-227.
  • Rousseau,Francois, 2010, "A non-local approach for image super-resolution using intermodality priors." MEDICAL IMAGE ANALYSIS 14, no. 4, 594-605 - 594-605.
  • Risacher,Shannon,L; Shen,Li; West,John,D; Kim,Sungeun; McDonald,Brenna,C; Beckett,Laurel,A; Harvey,Danielle,J; Jack,Clifford,R; Weiner,Michael,W; Saykin,Andrew,J, 2010, "Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort." NEUROBIOLOGY OF AGING 31, no. 8, 1401-1418 - 1401-1418.
  • Fjell,Anders,M; Walhovd,Kristine,B; Fennema-Notestine,Christine; McEvoy,Linda,K; Hagler,Donald,J; Holland,Dominic; Brewer,James,B; Dale,Anders,M, 2010, "CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease." JOURNAL OF NEUROSCIENCE 30, no. 6, 2088-2101 - 2088-2101.
  • Yushkevich,Paul,A; Avants,Brian,B; Das,Sandhitsu,R; Pluta,John; Altinay,Murat; Craige,Caryne, 2010, "Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: An illustration in ADNI 3 T MRI data." NEUROIMAGE 50, no. 2, 434-445 - 434-445.
  • Franke,Katja; Ziegler,Gabriel; Kloeppel,Stefan; Gaser,Christian, 2010, "Estimating the age of healthy subjects from T-1-weighted MRI scans using kernel methods: Exploring the influence of various parameters." NEUROIMAGE 50, no. 3, 883-892 - 883-892.
  • Holland,Dominic; Brewer,James,B; Hagler,Donald,J; Fenema-Notestine,Christine; Dale,Anders,M, 2010, "Subregional neuroanatomical change as a biomarker for Alzheimer's disease (vol 106, pg 20954, 2009)." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 107, no. 14, 6551-6551 - 6551-6551.
  • Desikan,Rahul,S; Cabral,Howard,J; Settecase,Fabio; Hess,Christopher,P; Dillon,William,P; Glastonbury,Christine,M; Weiner,Michael,W; Schmansky,Nicholas,J; Salat,David,H; Fischl,Bruce, 2010, "Automated MRI measures predict progression to Alzheimer's disease." NEUROBIOLOGY OF AGING 31, no. 8, 1364-1374 - 1364-1374.
  • Bossa,Matias; Zacur,Ernesto; Olmos,Salvador, 2010, "Tensor-based morphometry with stationary velocity field diffeomorphic registration: Application to ADNI." NEUROIMAGE 51, no. 3, 956-969 - 956-969.
  • McEvoy,Linda,K; Edland,Steven,D; Holland,Dominic; Hagler,Donald,J; Roddey,J,Cooper; Fennema-Notestine,Christine; Salmon,David,P; Koyama,Alain,K; Aisen,Paul,S; Brewer,James,B; Dale,Anders,M, 2010, "Neuroimaging Enrichment Strategy for Secondary Prevention Trials in Alzheimer Disease." ALZHEIMER DISEASE & ASSOCIATED DISORDERS 24, no. 3, 269-277 - 269-277.
  • Hua,Xue; Lee,Suh; Hibar,Derrek,P; Yanovsky,Igor; Leow,Alex,D; Toga,Arthur,W; Jack,Clifford,R; Bernstein,Matt,A; Reiman,Eric,M; Harvey,Danielle,J; Kornak,John; Schuff,Norbert; Alexander,Gene,E; Weiner,Michael,W; Thompson,Paul,M, 2010, "Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals." NEUROIMAGE 51, no. 1, 63-75 - 63-75.
  • Lorenzi,M; Donohue,M; Paternico,D; Scarpazza,C; Ostrowitzki,S; Blin,O; Irving,E; Frisoni,G,B, 2010, "Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment." NEUROBIOLOGY OF AGING 31, no. 8, 1443-1451 - 1443-1451.
  • Okonkwo,Ozioma,C; Alosco,Michael,L; Griffith,Randall; Mielke,Michelle,M; Shaw,Leslie,M; Trojanowski,John,Q; Tremont,Geoffrey, 2010, "Cerebrospinal Fluid Abnormalities and Rate of Decline in Everyday Function Across the Dementia Spectrum Normal Aging, Mild Cognitive Impairment, and Alzheimer Disease." ARCHIVES OF NEUROLOGY 67, no. 6, 688-696 - 688-696.
  • Ott,Brian,R; Cohen,Ronald,A; Gongvatana,Assawin; Okonkwo,Ozioma,C; Johanson,Conrad,E; Stopa,Edward,G; Donahue,John,E; Silverberg,Gerald,D, 2010, "Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease." JOURNAL OF ALZHEIMERS DISEASE 20, no. 2, 647-657 - 647-657.
  • Landau,S,M; Harvey,D; Madison,C,M; Reiman,E,M; Foster,N,L; Aisen,P,S; PETERSEN,R,C; Shaw,L,M; Trojanowski,J,Q; Jack,C,R; Weiner,M,W; Jagust,W,J, 2010, "Comparing predictors of conversion and decline in mild cognitive impairment." NEUROLOGY 75, no. 3, 230-238 - 230-238.
  • Risser,Laurent; Vialard,Francois-Xavier; Wolz,Robin; Holm,Darryl,D; Rueckert,Daniel, 2010, "Simultaneous Fine and Coarse Diffeomorphic Registration: Application to Atrophy Measurement in Alzheimer's Disease." MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2010, PT II, 6362, 610-617 - 610-617.
  • Wolz,Robin; Aljabar,Paul; Hajnal,Joseph,V; Hammers,Alexander; Rueckert,Daniel, 2010, "LEAP: Learning embeddings for atlas propagation." NEUROIMAGE 49, no. 2, 1316-1325 - 1316-1325.
  • Vounou,Maria; Nichols,Thomas,E; Montana,Giovanni, 2010, "Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach." NEUROIMAGE 53, no. 3, 1147-1159 - 1147-1159.
  • Wolz,Robin; Heckemann,Rolf,A; Aljabar,Paul; Hajnal,Joseph,V; Hammers,Alexander; Lotjonen,Jyrki; Rueckert,Daniel, 2010, "Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI." NEUROIMAGE 52, no. 1, 109-118 - 109-118.
  • Stein,Jason,L; Hua,Xue; Lee,Suh; Ho,April,J; Leow,Alex,D; Toga,Arthur,W; Saykin,Andrew,J; Shen,Li; Foroud,Tatiana; Pankratz,Nathan; Huentelman,Matthew,J; Craig,David,W; Gerber,Jill,D; Allen,April,N; Corneveaux,Jason,J; Dechairo,Bryan,M; Potkin,Steven,G; Weiner,Michael,W; Thompson,Paul,M, 2010, "Voxelwise genome-wide association study (vGWAS)." NEUROIMAGE 53, no. 3, 1160-1174 - 1160-1174.
  • Chou,Yi-Yu; Lepore,Natasha; Saharan,Priyanka; Madsen,Sarah,K; Hua,Xue; Jack,Clifford,R; Shaw,Leslie,M; Trojanowski,John,Q; Weiner,Michael,W; Toga,Arthur,W; Thompson,Paul,M, 2010, "Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline." NEUROBIOLOGY OF AGING 31, no. 8, 1386-1400 - 1386-1400.
  • Walhovd,K,B; Fjell,A,M; Brewer,J; McEvoy,L,K; Fennema-Notestine,C; Hagler,D,J; JENNINGS,R,G; Karow,D; Dale,A,M, 2010, "Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease." AMERICAN JOURNAL OF NEURORADIOLOGY 31, no. 2, 347-354 - 347-354.
  • Kauwe,John,SK; Cruchaga,Carlos; Bertelsen,Sarah; Mayo,Kevin; Latu,Wayne; Nowotny,Petra; Hinrichs,Anthony,L; Fagan,Anne,M; Holtzman,David,M; Goate,Alison,M, 2010, "Validating Predicted Biological Effects of Alzheimer's Disease Associated SNPs Using CSF Biomarker Levels." JOURNAL OF ALZHEIMERS DISEASE 21, no. 3, 833-842 - 833-842.
  • Wang,Hongzhi; Das,Sandhitsu; Pluta,John; Craige,Caryne; Altinay,Murat; Avants,Brian; Weiner,Michael; Mueller,Susanne; Yushkevich,Paul, 2010, "Standing on the Shoulders of Giants: Improving Medical Image Segmentation via Bias Correction." MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2010, PT III 6363, 105-112 - 105-112.
  • Yang,Wenlu; Chen,Xinyun; Xie,Hong; Huang,Xudong, 2010, "ICA-Based Automatic Classification of Magnetic Resonance Images from ADNI Data." LIFE SYSTEM MODELING AND INTELLIGENT COMPUTING 6330, 340-347 - 340-347.

2009

  • Joyner,Alexander,H; Roddey,J,Cooper; Bloss,Cinnamon,S; Bakken,Trygve,E; Rimol,Lars,M; Melle,Ingrid; Agartz,Ingrid; Djurovic,Srdjan; Topol,Eric,J; Schork,Nicholas,J; Andreassen,Ole,A; Dale,Anders,M, 2009, "A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 106, no. 36, 15483-15488 - 15483-15488.
  • Leow,Alex,D; Yanovsky,Igor; Parikshak,Neelroop; Hua,Xue; Lee,Suh; Toga,Arthur,W; Jack,Clifford,R; Bernstein,Matt,A; Britson,Paula,J; Gunter,Jeffrey,L; Ward,Chadwick,P; Borowski,Bret; Shaw,Leslie,M; Trojanowski,John,Q; Fleisher,Adam,S; Harvey,Danielle; Kornak,John; Schuff,Norbert; Alexander,Gene,E; Weiner,Michael,W; Thompson,Paul,M, 2009, "Alzheimer's Disease Neuroimaging Initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition." NEUROIMAGE 45, no. 3, 645-655 - 645-655.
  • Chou,Yi-Yu; Lepore,Natasha; Avedissian,Christina; Madsen,Sarah,K; Parikshak,Neelroop; Hua,Xue; Shaw,Leslie,M; Trojanowski,John,Q; Weiner,Michael,W; Toga,Arthur,W; Thompson,Paul,M, 2009, "Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls." NEUROIMAGE 46, no. 2, 394-410 - 394-410.
  • Gunter,Jeffrey,L; Bernstein,Matt,A; Borowski,Brett,J; Ward,Chadwick,P; Britson,Paula,J; Felmlee,Joel,P; Schuff,Norbert; Weiner,Michael; Jack,Clifford,R, 2009, "Measurement of MRI scanner performance with the ADNI phantom." MEDICAL PHYSICS 36, no. 6, 2193-2205 - 2193-2205.
  • Langbaum,Jessica,BS; Chen,Kewei; Lee,Wendy; Reschke,Cole; Bandy,Dan; Fleisher,Adam,S; Alexander,Gene,E; Foster,Norman,L; Weiner,Michael,W; Koeppe,Robert,A; Jagust,William,J; Reiman,Eric,M, 2009, "Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)." NEUROIMAGE 45, no. 4, 1107-1116 - 1107-1116.
  • Jack,Clifford,R; Lowe,Val,J; Weigand,Stephen,D; Wiste,Heather,J; Senjem,Matthew,L; Knopman,David,S; Shiung,Maria,M; Gunter,Jeffrey,L; Boeve,Bradley,F; Kemp,Bradley,J; Weiner,Michael; Petersen,Ronald,C, 2009, "Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease." BRAIN 132, 1355-1365 - 1355-1365.
  • Haense,C; Herholz,K; Jagust,W,J; Heiss,W,D, 2009, "Performance of FDG PET for Detection of Alzheimer's Disease in Two Independent Multicentre Samples (NEST-DD and ADNI)." DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 28, no. 3, 259-266 - 259-266.
  • Buerger,Katharina; Frisoni,Giovanni; Uspenskaya,Olga; Ewers,Michael; Zetterberg,Henrik; Geroldi,Cristina; Binetti,Giuliano; Johannsen,Peter; Rossini,Paolo,Maria; Wahlund,Lars-Olof; Vellas,Bruno; Blennow,Kaj; Hampel,Harald, 2009, "Validation of Alzheimer's disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)." EXPERIMENTAL GERONTOLOGY 44, no. 9, 579-585 - 579-585.
  • Querbes,Olivier; Aubry,Florent; Pariente,Jeremie; Lotterie,Jean-Albert; Demonet,Jean-Francois; Duret,Veronique; Puel,Michele; Berry,Isabelle; Fort,Jean-Claude; Celsis,Pierre, 2009, "Early diagnosis of Alzheimers disease using cortical thickness: impact of cognitive reserve." BRAIN 132, 2036-2047 - 2036-2047.
  • McDonald,C,R; McEvoy,L,K; Gharapetian,L; Fennema-Notestine,C; Hagler,D,J; Holland,D; Koyama,A; Brewer,J,B; Dale,A,M, 2009, "Regional rates of neocortical atrophy from normal aging to early Alzheimer disease." NEUROLOGY 73, no. 6, 457-465 - 457-465.
  • Schuff,N; Woerner,N; Boreta,L; Kornfield,T; Shaw,L,M; Trojanowski,J,Q; Thompson,P,M; Jack,C,R; Weiner,M,W, 2009, "MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers." BRAIN 132, 1067-1077 - 1067-1077.
  • Hua,Xue; Lee,Suh; Yanovsky,Igor; Leow,Alex,D; Chou,Yi-Yu; Ho,April,J; Gutman,Boris; Toga,Arthur,W; Jack,Clifford,R; Bernstein,Matt,A; Reiman,Eric,M; Harvey,Danielle,J; Kornak,John; Schuff,Norbert; Alexander,Gene,E; Weiner,Michael,W; Thompson,Paul,M, 2009, "Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects." NEUROIMAGE 48, no. 4, 668-681 - 668-681.
  • Misra,Chandan; Fan,Yong; Davatzikos,Christos, 2009, "Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI." NEUROIMAGE 44, no. 4, 1415-1422 - 1415-1422.
  • Jagust,W,J; Landau,S,M; Shaw,L,M; Trojanowski,J,Q; Koeppe,R,A; Reiman,E,M; Foster,N,L; PETERSEN,R,C; Weiner,M,W; Price,J,C; Mathis,C,A, 2009, "Relationships between biomarkers in aging and dementia." NEUROLOGY 73, no. 15, 1193-1199 - 1193-1199.
  • Davatzikos,Christos; Xu,Feng; An,Yang; Fan,Yong; Resnick,Susan,M, 2009, "Longitudinal progression of Alzheimers-like patterns of atrophy in normal older adults: the SPARE-AD index." BRAIN 132, 2026-2035 - 2026-2035.
  • Acosta,Oscar; Bourgeat,Pierrick; Zuluaga,Maria,A; Fripp,Jurgen; Salvado,Olivier; Ourselin,Sebastien, 2009, "Automated voxel-based 3D cortical thickness measurement in a combined Lagrangian-Eulerian PDE approach using partial volume maps." MEDICAL IMAGE ANALYSIS 13, no. 5, 730-743 - 730-743.
  • Risacher,Shannon,L; Saykin,Andrew,J; West,John,D; Shen,Li; Firpi,Hiram,A; McDonald,Brenna,C, 2009, "Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort." CURRENT ALZHEIMER RESEARCH 6, no. 4, 347-361 - 347-361.
  • Shaw,Leslie,M; Vanderstichele,Hugo; Knapik-Czajka,Malgorzata; Clark,Christopher,M; Aisen,Paul,S; Petersen,Ronald,C; Blennow,Kaj; Soares,Holly; Simon,Adam; Lewczuk,Piotr; Dean,Robert; Siemers,Eric; Potter,William; Lee,Virginia,MY; Trojanowski,John,Q, 2009, "Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects." ANNALS OF NEUROLOGY 65, no. 4, 403-413 - 403-413.
  • Fleisher,Adam,S; Donohue,Michael; Chen,Kewei; Brewer,James,B; Aisen,Paul,S, 2009, "Applications of neuroimaging to disease-modification trials in Alzheimer's disease.." Behavioural neurology 21, no. 1, 129-136 - 129-136.
  • Fjell,Anders,M; Walhovd,Kristine,B; Fennema-Notestine,Christine; McEvoy,Linda,K; Hagler,Donald,J; Holland,Dominic; Brewer,James,B; Dale,Anders,M, 2009, "One-Year Brain Atrophy Evident in Healthy Aging." JOURNAL OF NEUROSCIENCE 29, no. 48, 15223-15231 - 15223-15231.
  • Kovacevic,Sanja; Rafii,Michael,S; Brewer,James,B, 2009, "High-throughput, Fully Automated Volumetry for Prediction of MMSE and CDR Decline in Mild Cognitive Impairment." ALZHEIMER DISEASE & ASSOCIATED DISORDERS 23, no. 2, 139-145 - 139-145.
  • Joshi,Aniket; Koeppe,Robert,A; Fessler,Jeffrey,A, 2009, "Reducing between scanner differences in multi-center PET studies." NEUROIMAGE 46, no. 1, 154-159 - 154-159.
  • Fennema-Notestine,Christine; Hagler,Donald,J; McEvoy,Linda,K; Fleisher,Adam,S; Wu,Elaine,H; Karow,David,S; Dale,Anders,M, 2009, "Structural MRI Biomarkers for Preclinical and Mild Alzheimer's Disease." HUMAN BRAIN MAPPING 30, no. 10, 3238-3253 - 3238-3253.
  • Qiu,Anqi; Fennema-Notestine,Christine; Dale,Anders,M; Miller,Michael,I, 2009, "Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease." NEUROIMAGE 45, no. 3, 656-661 - 656-661.
  • Mortamet,Benedicte; Bernstein,Matt,A; Jack,Clifford,R; Gunter,Jeffrey,L; Ward,Chadwick; Britson,Paula,J; Meuli,Reto; Thiran,Jean-Philippe; Krueger,Gunnar, 2009, "Automatic Quality Assessment in Structural Brain Magnetic Resonance Imaging." MAGNETIC RESONANCE IN MEDICINE 62, no. 2, 365-372 - 365-372.
  • Huang,Albert; Abugharbieh,Rafeef; Tam,Roger, 2009, "A Hybrid Geometric-Statistical Deformable Model for Automated 3-D Segmentation in Brain MRI." IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING 56, no. 7, 1838-1848 - 1838-1848.
  • Vemuri,P; Wiste,H,J; Weigand,S,D; Shaw,L,M; Trojanowski,J,Q; Weiner,M,W; Knopman,D,S; PETERSEN,R,C; Jack,C,R, 2009, "MRI and CSF biomarkers in normal, MCI, and AD subjects Diagnostic discrimination and cognitive correlations." NEUROLOGY 73, no. 4, 287-293 - 287-293.
  • McEvoy,Linda,K; Fennema-Notestine,Christine; Roddey,J,Cooper; Hagler,Donald,J; Holland,Dominic; Karow,David,S; Pung,Christopher,J; Brewer,James,B; Dale,Anders,M, 2009, "Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment." RADIOLOGY 251, no. 1, 195-205 - 195-205.
  • Chupin,Marie; Gerardin,Emilie; Cuingnet,Remi; Boutet,Claire; Lemieux,Louis; Lehericy,Stephane; Benali,Habib; Garnero,Line; Colliot,Olivier, 2009, "Fully Automatic Hippocampus Segmentation and Classification in Alzheimer's Disease and Mild Cognitive Impairment Applied on Data From ADNI." HIPPOCAMPUS 19, no. 6, 579-587 - 579-587.

2008

  • Shaw,Leslie,M, 2008, "PENN biomarker core of the Alzheimer's disease neuroimaging initiative." NEUROSIGNALS 16, no. 1, 19-23 - 19-23.
  • Fan,Yong; Batmanghelich,Nematollah; Clark,Chris,M; Davatzikos,Christos, 2008, "Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline." NEUROIMAGE 39, no. 4, 1731-1743 - 1731-1743.
  • Hua,Xue; Leow,Alex,D; Parikshak,Neelroop; Lee,Suh; Chiang,Ming-Chang; Toga,Arthur,W; Jack,Clifford,R; Weiner,Michael,W; Thompson,Paul,M, 2008, "Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects." NEUROIMAGE 43, no. 3, 458-469 - 458-469.
  • Clark,C,M; Davatzikos,C; Borthakur,A; Newberg,A; Leight,S; Lee,VM,Y; Trojanowski,J,Q, 2008, "Biomarkers for early detection of Alzheimer pathology." NEUROSIGNALS 16, no. 1, 11-18 - 11-18.
  • Nestor,Sean,M; Rupsingh,Raul; Borrie,Michael; Smith,Matthew; Accomazzi,Vittorio; Wells,Jennie,L; Fogarty,Jennifer; Bartha,Robert, 2008, "Ventricular enlargement as a possible measure of Alzheimers disease progression validated using the Alzheimers disease neuroimaging initiative database." BRAIN 131, 2443-2454 - 2443-2454.
  • Frisoni,Giovanni,B; Henneman,Wouter,JP; Weiner,Michael,W; Scheltens,Philip; Vellas,Bruno; Reynish,Emma; Hudecova,Jaroslava; Hampel,Harald; Burger,Katharina; Blennow,Kaj; Waldemar,Gunhild; Johannsen,Peter; Wahlund,Lars-Olof; Zito,Giancarlo; Rossini,Paolo,M; Winblad,Bengt; Barkhof,Frederik, 2008, "The pilot European Alzheimer's disease neuroimaging initiative of the European Alzheimer's disease consortium." ALZHEIMERS & DEMENTIA 4, no. 4, 255-264 - 255-264.
  • Mueller,Susanne,G; Weiner,Michael,W; Thal,Leon,J; Petersen,Ronald,C; Jack,Clifford; Jagust,William; Trojanowski,John,Q; Toga,Arthur,W; Beckett,Laurel, 2008, "Alzheimer's disease neuroimaging initiative." ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES 57, 183-189 - 183-189.
  • Boyes,Richard,G; Gunter,Jeff,L; Frost,Chris; Janke,Andrew,L; Yeatman,Thomas; Hill,Derek,LG; Bernstein,Matt,A; Thompson,Paul,M; Weiner,Michael,W; Schuff,Norbert; Alexander,Gene,E; Killiany,Ronald,J; DeCarli,Charles; Jack,Clifford,R; Fox,Nick,C, 2008, "Intensity non-uniformity correction using N3 on 3-T scanners with mutichannel phased array coils." NEUROIMAGE 39, no. 4, 1752-1762 - 1752-1762.

2007

  • Beversdorf DQ, Ferguson JLW, Hillier A, Sharma UK, Nagaraja HN, Bornstein RA, Scharre DW, 2007, "Problem solving ability in patients with mild cognitive impairment." Cognitive Behavior Neurology 20, 44-47 - 44-47.
  • Fletcher,P,Thomas; Powell,Stephanie; Foster,Norman,L; Joshi,Sarang,C, 2007, "Quantifying metabolic asymmetry modulo structure in Alzheimer's disease.." Information processing in medical imaging : proceedings of the ... conference 20, 446-457 - 446-457.
  • Beversdorf DQ; Ferguson JL; Hillier A; Sharma UK; Nagaraja HN; Bornstein RA; Scharre DW, 2007, "Problem solving ability in patients with mild cognitive impairment.." Cognitive And Behavioral Neurology: Official Journal Of The Society For Behavioral And Cognitive Neurology 20, no. 1, 44 - 44.

2006

  • Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC, 2006, "Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.." Clinical Therapeutics 28, no. 10, 1695 - 1695.
  • Caballero J; Hitchcock M; Beversdorf D; Scharre D; Nahata M, 2006, "Long-term effects of antidepressants on cognition in patients with Alzheimer's disease.." Journal Of Clinical Pharmacy And Therapeutics 31, no. 6, 593 - 593.
  • Leow,Alex,D; Klunder,Andrea,D; Jack,Clifford,R; Toga,Arthur,W; Dale,Anders,M; Bernstein,Matt,A; Britson,Paula,J; Gunter,Jefftey,L; Ward,Chadwick,P; Whitwell,Jennifer,L; Borowski,Bret,J; Fleisher,Adam,S; Fox,Nick,C; Harvey,Danielle; Kornak,John; Schuff,Norbert; Studholme,Colin; Alexander,Gene,E; Weiner,Michael,W; Thompson,Paul,M, 2006, "Longitudinal stability of MRI for mapping brain change using tensor-based morphometry." NEUROIMAGE 31, no. 2, 627-640 - 627-640.
  • Truong TK; Chakeres DW; Beversdorf DQ; Scharre DW; Schmalbrock P, 2006, "Effects of static and radiofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging.." Magnetic Resonance Imaging 24, no. 2, 103-112 - 103-112.
  • Scharre,Douglas,W, 2006, "Galantamine with adjunctive memantine: Combined effects on brain nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors may improve Alzheimer's disease symptomatology - Introduction." JOURNAL OF CLINICAL PHARMACOLOGY 46, no. 7, 6S-7S - 6S-7S.

2005

  • Mueller,Susanne,G; Weiner,Michael,W; Thal,Leon,J; Petersen,Ronald,C; Jack,Clifford,R; Jagust,William; Trojanowski,John,Q; Toga,Arthur,W; Beckett,Laurel, 2005, "Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).." Alzheimer's & dementia : the journal of the Alzheimer's Association 1, no. 1, 55-66 - 55-66.

2004

  • Scharre DW, 2004, "The complex interaction of cognitive issues." Psychiatric Times 21, 37-38 - 37-38.

2003

  • Klatte ET; Scharre DW; Nagaraja HN; Davis RA; Beversdorf DQ, 2003, "Combination therapy of donepezil and vitamin E in Alzheimer disease.." Alzheimer Disease And Associated Disorders 17, no. 2, 113 - 113.
  • Scharre DW; Davis RA; Warner JL; Chang SI; Beversdorf DQ, 2003, "A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease.." The American Journal Of Geriatric Psychiatry: Official Journal Of The American Association For Geriatric Psychiatry 11, no. 6, 687 - 687.

2002

  • Scharre DW; Chang SI, 2002, "Cognitive and behavioral effects of quetiapine in Alzheimer disease patients.." Alzheimer Disease And Associated Disorders 16, no. 2, 128 - 128.
  • Scharre D, Grossman M, Mayeux R, Cummings J (Contributors), 2002, "How to treat dementia in its early stages." Practical Neurology 1, 60 - 60.
  • Scharre DW, Chang S-I, 2002, "Cognitive and behavioral effects of quetiapine in Alzheimer disease patients." Alzheimer's Disease and Associated Disorders 16, 128-130 - 128-130.
  • Scharre, DW, Chang, S-I, 2002, "Cognitive and behavioral effects of quetiapine in Alzheimer disease patients." Alzheimer's Disease and Associated Disorders 16, 128-130 - 128-130.

2000

  • Van Dyck CH, Newhouse P, Falk WE, Mattes JA, and the Physostigmine Study Group including Scharre DW, 2000, "Extended-release physostigmine in Alzheimer's Disease." Arch Gen Psychiatry 57, 157-164 - 157-164.
  • Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C, and the Galantamine USA-10 Study Group including Scharre D, 2000, "A 5-month, randomized, placebo-controlled trial of galantamine in AD." Neurology 54, 2269-2276 - 2269-2276.

1996

  • Mega MS; Masterman DL; Benson DF; Vinters HV; Tomiyasu U; Craig AH; Foti DJ; Kaufer D; Scharre DW; Fairbanks L; Cummings JL, 1996, "Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria.." Neurology 47, no. 6, 1403 - 1403.

1995

  • Chang L, Scharre DW, Miller B, Cummings JL, Vigo-Pelfry C, Schenk D, 1995, "B-amyloid protein in cerebrospinal fluid of Alzheimer's disease: correlations with MMSE scores." Facts and Research in Gerontology 9, 84-92 - 84-92.

1986

  • Scharre,D; Petri,M; Engman,E; DeArmond,S, 1986, "LARGE INTRACRANIAL ARTERITIS WITH GIANT-CELLS IN SYSTEMIC LUPUS-ERYTHEMATOSUS." ANNALS OF INTERNAL MEDICINE 104, no. 5, 661-662 - 661-662.

Unknown

  • Scharre DW, Chang S-I, Nagaraja HN, Yager-Schweller J, Murden RA, "Community cognitive screening using the Self-Administered Gerocognitive Examination (SAGE)." J Neuropsychiatry Clin Neurosci

Presentations

  • "Early identification of Alzheimer's disease: Biomarkers, imaging, and cognitive assessment." 2012, Presented at BIT's 3rd Annual World Congress of NeuroTalk-2012,
  • "Magnetic Resonance and Computer Tomography in Jadassohn's Nevus Phakomatosis: Comparison in Two Cases." 1986, Presented at Seventh Annual Army Medical Department (AMEDD) Neurology Conference,
  • "Driving performance in Alzheimer's disease is predicted by easily administered cognitive tasks." 2000, Presented at 51st Annual Meeting of the American Academy of Neurology,
  • "Antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine versus donepezil: Evidence from health claims data." 2008, Presented at American Society of Consultant Pharmacists 2008 Annual Meeting,
  • "Memantine in frontotemporal dementia." 2009, Presented at American Neuropsychiatric Association (ANPA) 20th Annual Meeting,
  • "Self-Administered Screening Uncovers Mild Cognitive Impairment and Dementia Among Community Dwelling Seniors." 2011, Presented at American Neuropsychiatric Association (ANPA) 22nd Annual Meeting,
  • "Characteristics of the Self-Administered Gerocognitive Examination (SAGE) used as a screening tool." 2011, Presented at International Conference on Alzheimer's Disease (ICAD),
  • "Cognitive biomarkers: SAGE screening for the early identification of mild cognitive impairment and Alzheimer’s disease." 2012, Presented at International Conference and Exhibition on Neurology & Therapeutics,
  • "Memory profiles differ between Parkinsonain dementia syndromes and Alzheimer’s disease." 2012, Presented at Alzheimer’s Disease International Conference (AAIC) 2012,
  • "Distinguishing Parkinsonian dementia syndromes from Alzheimer’s disease: Cognitive, behavioral and motor characteristics." 2013, Presented at BIT's 4th Annual World Congress of NeuroTalk-2013,
  • "Citalopram reduces restless activity and aberrant motor behaviors in Alzheimer's dementia." 2002, Presented at American Association for Geriatric Psychiatry (AAGP),
  • "Validity of a self-administered test for detection of Mild Cognitive Impairment (MCI) and early dementia." 2008, Presented at International Conference on Alzheimer's Disease (ICAD),
  • "Self-Administered Gerocognitive Examination (SAGE) score changes over time in worried well, Mild Cognitive Impairment (MCI), and dementia converter patients." 2010, Presented at American Neuropsychiatric Association (ANPA) 21st Annual Meeting,
  • "Self Administered Gerocognitive Examination (SAGE) and Mini-Mental State Examination (MMSE) score changes over time in worried well, Mild Cognitive Impairment (MCI), and dementia converter patients." 2010, Presented at 61st Annual Meeting of the American Academy of Neurology,
  • "Diagnostic Tests for Common Neurological Disorders." 2010, Presented at Neurotalk 2010,
  • "Cognitive screening for Mild Cognitive Impairment and early dementia." 2010, Presented at Neurotalk 2010,
  • "Self Administered Gerocognitive Examination (SAGE) score changes over time in worried well, Mild Cognitive Impairment (MCI), dementia converter, and Alzheimer's disease patients." 2010, Presented at International Conference on Alzheimer's Disease (ICAD),
  • "Community Outreach Self-Administered Screening Uncovers Mild Cognitive Impairment and Dementia Among Seniors." 2011, Presented at 62nd Annual Meeting of the American Academy of Neurology,
  • "Frontotemporal lobar degeneration: Clinical, imaging, and pathologic features." 2011, Presented at BIT's 2nd Annual World Congress of Neurotalk 2011,
  • "Behavioral and Cognitive Neuroscience." 2011, Presented at BIT's 2nd Annual World Congress of Neurotalk 2011,
  • "Differences in the cognitive profiles of Parkinsonian dementia syndromes and Alzheimer’s disease." 2012, Presented at American Medical Directors Association (AMDA) annual meeting 2012,
  • "Early identification of Alzheimer’s disease: Biomarkers, imaging, and cognitive assessment. Part 2." 2012, Presented at BIT's 3rd Annual World Congress of NeuroTalk-2012,
  • "Atypical antipsychotic efficacy and tolerability in dementia subjects living at a long-term care facility: A retrospective study." 2013, Presented at Alzheimer’s Disease International Conference (AAIC) 2013,
  • "Magnetic Resonance and Computer Tomography in Jadassohn's Nevus Phakomatosis: Comparison in Two Cases." 1986, Presented at Child Neurology Society Meeting,
  • "Primary Mumps Encephalitis with Initial Signs of Cerebellar Ataxia, Cortical Blindness, and Light Near Dissociation: Unusual Progression with Residua." 1986, Presented at Seventh Annual Army Medical Department (AMEDD) Neurology Conference,
  • "Neuropsychiatric features of chorea-acanthocytosis." 1994, Presented at 46th Annual Meeting of the American Academy of Neurology,
  • "SPECT imaging in frontotemporal degeneration: anatomical correlations with apathy and disinhibition." 1996, Presented at 48th Annual Meeting of the American Academy of Neurology,
  • "Dystonia as the Initial Manifestation of Multiple Sclerosis." 1988, Presented at Ninth Annual Army Medical Department (AMEDD) Neurology Conference,
  • "Emergent use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: Evidence from health claims data." 2009, Presented at Academy of Managed Care Pharmacy 21st Annual Meeting,
  • "Memantine in frontotemporal dementia." 2005, Presented at 57th Annual Meeting of the American Academy of Neurology,
  • "Patterns of asymmetry on SPECT imaging in Alzheimer's disease subjects with psychosis compared to those without behavioral disturbances." 2004, Presented at American Association for Geriatric Psychiatry (AAGP),
  • "Antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine versus donepezil: Evidence from health claims data." 2008, Presented at International Conference on Alzheimer's Disease (ICAD),
  • "Antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine versus donepezil: Evidence from health claims data." 2009, Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual International Meeting,

Papers in Proceedings

2013

  • Scharre, DW "Distinguishing Parkinsonian dementia syndromes from Alzheimer’s disease: Cognitive, behavioral and motor characteristics." in BIT's 4th Annual World Congress on NeuroTalk 2013. (5 2013).
  • Scharre DW, Chang S-I, Nagaraja HN Agrawal P, Kataki M, Linder S, Park A "Distinguishing Parkinsonian dementia syndromes from Alzheimer’s disease: Behavioral and cognitive characteristics using SAGE." in 64th Annual Meeting of the American Academy of Neurology. (3 2013).
  • Fritz NE, Kegelmeyer DA, Scharre D, Chang S, Kloos AD "Comparison of gait and mobility measures in dementia with Lewy bodies, Parkinson's disease with dementia, ALzheimer's disease and Parkinson's disease." in APTA Combined Sections Meeting. (1 2013).
  • Scharre DW, Chang S-I, Nagaraja H, Merjanian M, Greenley G, Davis R "Atypical antipsychotic efficacy and tolerability in dementia subjects living at a long-term care facility: A retrospective study." in Alzheimer’s Disease International Conference (AAIC) 2013. (7 2013).

2012

  • Scharre D, Chang S-I, kataki M, Agrawal P, Park A, Kostyk S, Kovesci R, Davis R, Nagaraja H "Memory profiles differ between Parkinsonain dementia syndromes and Alzheimer’s disease." in Alzheimer’s Disease International Conference (AAIC) 2012. (7 2012).
  • Scharre D, Chang S, Kataki M, Agrawal P, Park A, Kostyk AS, Davis R, Kovesci R, Nagaraja H "Differences in the cognitive profiles of Parkinsonian dementia syndromes and Alzheimer’s disease." in American Medical Directors Association (AMDA) annual meeting 2012. (3 2012).
  • Scharre, Douglas W. "Early identification of Alzheimer's disease: Biomarkers, imaging, and cognitive assessment." in BIT's 3rd Annual World Congress of NeuroTalk-2012. (5 2012).
  • Scharre, Douglas W "Cognitive Biomarkers: SAGE screening for the early identification of mild cognitive impairment and Alzheimer's disease." in International Conference and Exhibition on Neurology & Therapeutics. (5 2012).

2011

  • Scharre,D,W; Chang,S-I; Levin,A; Nagaraja,H,N "Self-Administered Screening Uncovers Mild Cognitive Impairment and Dementia Among Community-Dwelling Seniors." (3 2011).
  • Scharre, DW "Frontotemporal lobar degeneration: Clinical, imaging, and pathologic features." in BIT's 2nd Annual World Congress of NeuroTalk 2011. (5 2011).
  • Abduljalil AM, Scharre D, Stoicea N, Narayanan A, Knopp M, Schmalbrock P "Brain function mapping of pre-mild cognitive impairment." in International Society of Magnetic Resonance in Medicine (ISMRM) meeting. (5 2011).
  • Scharre DW, Chang, S-I, Kataki M, Nagaraja HN, "Community Outreach Self-Administered Screening Uncovers Mild Cognitive Impairment and Dementia Among Seniors." in 62nd Annual Meeting of the American Academy of Neurology. (4 2011).
  • Scharre DW, Chang S-I, Murden RA, Osei K, Nagaraja HN "Characteristics of the Self-Administered Gerocognitive Examination (SAGE) used as a screening tool." in International Conference on Alzheimer's Disease (ICAD) 2011. (7 2011).

2010

  • Scharre,Douglas,W; Chang,Shu-Ing; Kataki,Maria; Nagaraja,Haikady,N "Self Administered Gerocognitive Examination (SAGE) and Mini-Mental State Examination (MMSE) Score Changes over Time in Worried Well, Mild Cognitive Impairment (MCI) and Dementia Converter Patients." in 62nd Annual Meeting of the American-Academy-of-Neurology. (3 2010).
  • Scharre DW, Chang, S-I, Kataki M, Nagaraja HN "Self Administered Gerocognitive Examination (SAGE) and Mini-Mental State Examination (MMSE) score changes over time in worried well, Mild Cognitive Impairment (MCI), and dementia converter patients." in 61st Annual Meeting of the American Academy of Neurology. (4 2010).
  • Scharre, DW "Cognitive screening for Mild Cognitive Impairment and early dementia.." in BIT's 1st Annual World Congress of NeuroTalk 2010. (6 2010).
  • Scharre DW, Chang, S-I, Wheeler NC, Kataki M, Nagaraja HN "Self Administered Gerocognitive Examination (SAGE) score changes over time in worried well, Mild Cognitive Impairment (MCI), dementia converter, and Alzheimer's disease patients." in International Conference on Alzheimer's Disease (ICAD) 2010. (7 2010).
  • Scharre DW, Chang, S-I, Kataki M, Nagaraja HN "Self Administered Gerocognitive Examination (SAGE) score changes over time in worried well, Mild Cognitive Impairment (MCI), and dementia converter patients." in American Neuropsychiatric Association (ANPA) 21st Annual Meeting. (3 2010).

2009

  • Scharre DW, Vekeman F, Lefebvre P, Kahler KH, Mody-Patel N, Duh MS "Emergent use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: Evidence from health claims data." in Academy of Managed Care Pharmacy 21st Annual Meeting. (4 2009).
  • Scharre DW, Lefebvre P, Vekeman F, Kahler KH, Turk F, Duh MS "Antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine versus donepezil: Evidence from health claims data." in International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual International Meeting. (5 2009).
  • Lefebvre,P; Vekeman,F; Kahler,K; Mody-Patel,N; Duh,M,S; Scharre,D,W "ANTIPSYCHOTIC DRUG USE IN PATIENTS WITH ALZHEIMER'S DISEASE TREATED WITH RIVASTIGMINE VERSUS DONEPEZIL: EVIDENCE FROM HEALTH CLAIMS DATA." (5 2009).

2008

  • Scharre DW, Chang S, Murden R, Lamb J, Beversdorf DQ, Kataki M, Nagaraja H, Bornstein R "Validity of a self-administered test for detection of Mild Cognitive Impairment (MCI) and early dementia." (7 2008).
  • Scharre D, Chang S-I, Beversdorf D, Kataki M, Nagaraja H, Bornstein R "Self-Administered Gerocognitive Examination (SAGE): Validity and reliability of a brief cognitive screening instrument for Mild Cognitive Impairment (MCI) and early dementia." in 60th Annual Meeting of the American Academy of Neurology. (4 2008).
  • Scharre DW, Lefebvre P, Vekeman F, Foreix J, Kahler KH, Turk F, Duh MS "Antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine versus donepezil: Evidence from health claims data." in International Conference on Alzheimer's Disease (ICAD) 2008. (7 2008).
  • Scharre DW, Chang S, Murden R, Lamb J, Beversdorf DQ, Kataki M, Nagaraja H, Bornstein R "Self-administered test to screen for mild cognitive impairment and early dementia." in American Geriatrics Society 2008 Annual Scientific Meeting. (5 2008).
  • Scharre DW, Change S, Murden R, Lamb J, Beversdorf DQ, Kataki M, Nagaraja H, Bornstein R "Self-administered test to screen for mild cognitive impairment and early dementia." (5 2008).

2007

  • Narayanan A, White CA, Kim N, Tivarus M, Hillier A, Schmalbrock P, Kataki M, Scharre D, Beversdorf D, "Effect of cholinesterase inhibitors on parietal lobe activation during a spatial attention task in MCI." in 14th Annual Meeting of the American Academy of Neurology. (5 2007).

2006

  • Truong,T,K; Chakeres,D,W; Beversdorf,D,Q; Scharre,D,W; Schmalbrock,P "Effects of static and radiofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging." in 12th Annual Meeting of the International-Society-for-Magnetic-Resonance-in-Medicine. (2 2006).

2005

  • Scharre,D,W; Warner,J,L; Knick,J,A; Davis,R,A; Theado-Miller,N "Memantine in frontotemporal dementia." in 57th Annual Meeting of the American-Academy-of-Neurology. (3 2005).
  • Scharre DW, Ferguson JL, Knick RA, Davis RA, Theado-Miller, N, Chang, S-I "Memantine in frontotemporal dementia." in 57th Annual Meeting of the American Academy of Neurology. (4 2005).

2004

  • Burkhart J, Scharre DW "Patterns of asymmetry on SPECT imaging in Alzheimer's disease subjects with psychosis compared to those without behavioral disturbances." in American Association for Geriatric Psychiatry (AAGP). (2 2004).
  • Caballero J, Hitchock M, Scharre D, Beversdorf D, Nahata MC "Atypical antipsychotic treatment in Alzheimer's disease: Effect on cognition." in Poster Presentation at the 2004 Annual Meeting of the American College of Clinical Pharmacology, Dallas, Texas. (10 2004).
  • Hitchock M, Caballero J, Beversdorf D, Scharre D, Nahata MC "Adjunctive therapy in Alzheimer's disease: Is vitamin E neuroprotective?." in Poster presentation at the 2004 Annual Meeting of the American College of Clinical Pharmacology, Dallas, Texas. (10 2004).
  • Caballero J, Hitchock M, Scharre D, Beversdorf D, Nahata MC "Effect of antidepressants on cognition in Alzheimer's disease." in Poster Presentation at the 2004 October Annual Meeting of the American College of Clinical Pharmacology, Dallas, Texas. (10 2004).
  • Beversdorf DQ, Warner JL, Sharma UK, Bornstein RA, Nagaraja HN, Scharre DW, Al-Dahhak R, "Performance on problem solving tasks as a measure for cholinesterase inhibitor treatment response in mild cognitive impairment." in Poster Presentation at the 56th Annual Meeting of the American Academy of Neurology, San Francisco, California. (4 2004).
  • Whitaker CD, Troung T-K, Dashner RA, Beversdorf DQ, Scharre D, Ruegsegger M, Olesik J, Pavlicova M, Abduljalil A, Chakeres DW, Schmalbrock P, "Assessment of iron with 8T MRI T2 imaging in human brain." in International Society of Magnetic Resonance in Medicine (ISMRM) 12th Scientific Meeting. (7 2004).

2003

  • Whitaker CD, Scharre DW, Beversdorf DQ, Pavlicova M, Chaudhury AR, Dashner RA, Smith MA, Perry G, Chakeres DW, Schmalbrock P "Hahn, CPMG, and combined analysis of T2 relaxation in the Alzheimer's hippocampus using a mixed effects model." in International Society of Magnetic Resonance in Medicine (ISMRM). (7 2003).
  • Scharre,D,W; Davis,R,A; Warner,J,L; Chang,S,I; Beversdorf,D,Q "A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease." in 15th Annual Meeting of the American-Association-for-Geriatric-Psychiatry. (11 2003).
  • Rabinowicz A, Koumaras B, Cummings J, Nousalehi M, Mirski D, and the Rivastigmine Nursing Home Study Team including Scharre DW "Effects of rivastigmine treatment on the psychiatric and behavioral disturbances of nursing home residents with moderate to severe Alzheimer's disease (final results)." in International Psychogeriatric Association Meeting. (5 2003).

2002

  • Chakeres DW, Novak P, DePhilip R, Abduljalil AM, Kangarlu A, Novak V, Dashner RA, Sloan HW, Whitaker C, Scharre DW, Santi M "Correlation of in vivo and cadaveric brainstem anatomy using 8 tesla ultra high-resolution MRI." in International Society of Magnetic Resonance in Medicine (ISMRM). (5 2002).
  • Whitaker CDS, Scharre DW, Beversdorf DQ, Santi MS, Dashner RA, Chakeres DW, Schmalbrock P "T2 and T2* relaxation in normal and Alzheimer's formalin fixed hippocampus at 8T." in International Society of Magnetic Resonance in Medicine (ISMRM). (5 2002).
  • Chakeres DW, Scharre D, Beversdorf D, Santi M, Dashner R, Kangarlu A, et al. "Correlation of in vivo and cadaver high-resolution hippocampal MRI anatomy at 8 tesla." in Internal Society of Magnetic Resonance in Medicine (ISMRM). (5 2002).
  • Whitaker CDS, Scharre DW, Beversdorf DQ, RayChaudhry A, Dashner RA, Chakeres DW, Schmalbrock P "T2 relaxation in normal and Alzheimer's Hippocampus at 8T." in Hunt-Curtis Symposium on translational Neuroscience. (7 2002).

2001

  • Whitaker CDS, Schmalbrock PMF, Dashner RA, Beversdorf DQ, Santi MS, Abduljalil AM, Truong TK, Kangarlu A, DePhilip RM, Kuret J, Chakeres DW, Scharre DW "Ultra-high field magnetic resonance imaging signal intensity change in Alzheimer's disease." in Society for Neuroscience. (11 2001).
  • Chakeres,D,W; Novak,P; Dephilip,R; Abduljalli,A,M; Kangarlu,A; Novak,V, Dashner,RA; Sloan,HW; Whitaker,C; Scharre,DW; Santi,M "Correlation of in vivo and cadaveric brainstem anatomy using 8 Tesla ultra high-resolution MRI." in RSNA annual meeting 2001. (11 2001).
  • Chakeres DW, Dashner R, Kangarlu A, Whitaker CW, Abduljalil AM, Beversdorf DQ, Scharre DW, Slone HW, Santi M, Schmalbrock P, DePhilip RM "Microvasculature of the brain: correlation of in vivo and cadaveric vessels using 8 Tesla ultra high resolution MRI." in RSNA annual meeting 2001. (11 2001).

1996

  • Wasielewski P, Scharre D "PET scan in a case of late onset Huntington's disease with minimal dementia and absence of caudate atrophy." in American Society of Neuroimaging. (3 1996).

1995

  • Carroll BT, Clements HR, Scharre DW "Negative SPECT scans in three patients with catatonia due to dementia." in 148th Annual Meeting of the American Psychiatric Association. (5 1995).
  • Mega MS, Masterman D, Vinters H, Tomiyasu U, Nam P, Scharre D, Craig AH, Forti D, Benson DF "Diffuse Lewy body disease: a clinical-pathologic study." in 47th Annual Meeting of the American Academy of Neurology. (5 1995).

1994

  • Chang L, Miller BL, Scharre DW, Cummings J, Vigo-Pelfry C, Schenk D "B-amyloid protein in cerebrospinal fluid of Alzheimer disease: correlations with MMSE." in 46th Annual Meeting of the American Academy of Neurology. (5 1994).
  • Munroe WA, Southwick PC, Fu PC, Chang L, Miller BL, Scharre DW, Echols CL Jr, Whaley JM, Wolfert RL "Measurement of tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease." in Clinical Science of Aging Seminar of the meeting of the Association of Clinical Scientists. (11 1994).

1990

  • Lips DC, Scharre DW "Spontaneous Nontraumatic Vertebral Artery Dissection." (7 1990).

1988

  • Scharre, DW "Dystonia as the Initial Manifestation of Multiple Sclerosis." in Ninth Annual Army Medical Department (AMEDD) Neurology. (11 1988).

1986

  • Scharre DW, Powe LK "Magnetic Resonance and Computer Tomography in Jadassohn's Nevus Phakomatosis: Comparison in Two Cases." in Child Neurology Society. (10 1986).
  • Scharre DW and Gelinas-Sorrel D. "Primary Mumps Encephalitis with Initial Signs of Cerebellar Ataxia, Cortical Blindness, and Light Near Dissociation: Unusual Progression with Residua." in Seventh Annual Army Medical Department (AMEDD) Neurology Conference. (11 1986).
  • Scharre DW and Powe LK "Magnetic Resonance and Computer Tomography in Jadassohn's Nevus Phakomatosis: Comparison in Two Cases." in Seventh Annual Army Medical Department (AMEDD) Neurology Conference. (11 1986).

Unknown

  • Mascarenhas R, Scharre DW, Kataki M, Sadee W "Multiplexed RNA amplicon sequencing reveals altered gene expression and functional regulatory variants in dementia with Lewy bodies." in Neuroscience 2013.